Brain implant that learns: new hope for Parkinson's?

NCT ID NCT07216976

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests an adaptive deep brain stimulation (aDBS) system that automatically adjusts stimulation based on real-time brain signals. It aims to improve symptom control for 62 people with Parkinson's disease in China who already have a compatible brain implant. The main goal is to see if aDBS can maintain or increase 'good on' time (symptom relief without troublesome movements) compared to standard continuous stimulation.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Adaptive deep brain stimulation (aDBS) device
What this could lead to
If successful, this could offer a more personalized, responsive way to manage Parkinson's symptoms, potentially improving daily function without increasing side effects.
What could go wrong
This is a small, early-stage study (62 people) focused on feasibility and short-term outcomes. The adaptive algorithm may not work for everyone, and benefits over standard stimulation are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huashan Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, China

  • Ruijin Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, China

  • Sun Yat-sen Hospital

    RECRUITING

    Guangzhou, Guangdong, China

  • West China Hospital

    RECRUITING

    Chengdu, Sichuan, China

  • Xuanwu Hospital

    RECRUITING

    Beijing, Beijing Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.